September 25, 2017
A Pennsylvania federal court dismissed Monday a health plan's potential class action accusing more than a dozen major drugmakers of fixing the prices of generic drugs, saying the plan couldn't have relied on the alleged misconduct of the drugmakers when deciding how much it owed providers based on its own experience.
July 24, 2017
A Pennsylvania federal judge ruled Monday that 11 generic pharmaceutical entities based outside the state still must face price-fixing allegations in a union health insurance plan's putative class action, but she threw out claims against four drugmakers that do not sell drugs in the state, finding the court lacked jurisdiction.